©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 116957
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.116957
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.116957
Advancements in hepatic haemangioma surgery: An update-review of protocols, techniques, and postoperative outcomes
Sofia Rozani, Second Department of Surgery, Aretaieio University Hospital, National and Kapodistrian University of Athens, Athens 11528, Greece
Vasileios Vougas, First Department of Surgery and Transplant Unit, “Evangelismos” Hospital, Athens 11521, Greece
Author contributions: Rozani S and Vougas V both contributed to this paper.
Conflict-of-interest statement: All authors have no conflict of interest relevant to this study.
Corresponding author: Sofia Rozani, MD, PhD, Academic Fellow, Research Fellow, Second Department of Surgery, Aretaieio University Hospital, National and Kapodistrian University of Athens, Vas Sofias Street 76, Athens 11528, Greece. sofrozan@gmail.com
Received: November 25, 2025
Revised: December 12, 2025
Accepted: December 26, 2025
Published online: February 27, 2026
Processing time: 93 Days and 12.5 Hours
Revised: December 12, 2025
Accepted: December 26, 2025
Published online: February 27, 2026
Processing time: 93 Days and 12.5 Hours
Core Tip
Core Tip: Hepatic haemangiomas are common benign liver lesions that typically require surgery only when symptomatic or complicated. Recent progress in minimally invasive and robotic techniques, enhanced intraoperative guidance, and optimized recovery pathways has significantly improved surgical safety and outcomes. Meanwhile, artificial intelligence is emerging as a valuable tool for precise lesion assessment and individualized surgical planning. Continued refinement of patient selection and standardized perioperative protocols will be key to maximizing treatment effectiveness.